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Introduction

Methods

Type 1 Diabetes (T1D) is an autoimmune disease, in which insulinproducing cells are destroyed1. Insulin is an important transport and
signal molecule in glycolysis2. While T1D is treatable with insulin therapy,
little is known about how glycolysis is effected by the progression of T1D.
Metabolomics is a data-based approach for identifying and quantifying
metabolic compounds in biological samples3. One of the most common
tools in metabolomics is nuclear magnetic resonance (NMR)
spectroscopy, because it is non-destructive and quantitative4. NMR
measures the emission frequency of nuclei excited by an applied
electromagnetic field, producing a spectrum that can be used for the
metabolomic fingerprinting of biological samples. This experiment aimed
to identify and quantify key biomarkers in urine samples from T1D-prone
rats and to develop a protocol for processing tissue samples that can be
used in later experiments using NMR spectroscopy.
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NMR spectra of standard metabolite solutions were used to
create a reference library with MestReNova software.
Urine samples were obtained from LEW.1WR1 rats given either
a high-fat diet or a normal diet and were normalized using the
fluorescence emission of urochrome.
Muscle tissue samples were obtained from control rats and
processed with 70% ethanol to remove proteins and lipids.
Urine and tissue samples were analyzed on a Varian Unity
INOVATM 500 MHz NMR spectrometer, using a PROTON
experiment with 128 scans, 6s acquisition, 25s relaxation delay
and receiver gain of 30.
Metabolites in the samples were identified and quantified by
analyzing the sample spectra against the reference library.

Results
A single characteristic peak was used to
quantify each metabolite (see figures a and c).
In rats given a high fat diet, elevated levels of
glucose, 3-hydroxybutyrate, and acetoacetate
were noted in urine. Glycolytic intermediates
were not found in the urine samples, but
glucose 6-phosphate (G6P), fructose 6phosphate (F6P), fructose 1,6-bisphosphate
(F1,6BP),
3-phosphoglycerate
(3PG),
dihydroxyacetone phosphate (DHAP), and
pyruvate were found in muscle tissue samples
(see figure c). Phosphoenolpyruvate (PEP)
was not detected. After precipitating proteins in
70% ethanol, peaks that indicate the presence
of protein (~5.5ppm) were no longer present in
the NMR spectra. When the tissue extraction
protocol was carried out several times, similar
quantities of all metabolites but PEP were
obtained once the concentration was
normalized to the weight of the tissue (see
figure d).
Figure a: Typical NMR spectrum obtained from rat urine
with characteristic peaks used for identification labeled.
Figure b: Graph comparing the average metabolite
concentrations in the normalized and non-normalized urine
of high-fat and control rats. Figure c: Typical NMR
spectrum obtained from rat muscle tissue. Figure d: Graph
showing average metabolite concentrations in different
samples taken from the same rat muscle.

Discussion and Conclusions
The reference library created for the quantification of metabolites via NMR allows for single-peak identification of numerous molecules associated with
T1D in rat urine. This technique has proven sensitive enough to differentiate between α-glucose and β-glucose. Additionally, the urine of rats given a
high-fat diet showed increased amounts of acetoacetate and 3-hydroxybutyrate, indicators of ketoacidosis, which is a common risk for those with
T1D. The normalization of urine samples using urochrome improved variation among the high-fat samples and control samples. Additional work will
improve this normalization technique. The findings of the tissue analysis show that proteins can be removed from tissue to yield a clearer NMR
spectra and reduce peak overlaps. PEP was not identified in tissue NMR spectra, perhaps indicating that the reaction converting PEP to pyruvate
may occur too quickly for PEP to be detected. Furthermore, the large standard deviation for 3PG could be the result of peak overlaps with F6P or
F1,6BP. Further work is needed using other metabolomics techniques, such as LC-MS, to confirm the findings of this study.
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